|
|
|
Content :
News 2008
Press releases are intended for journalists, investors and shareholders.
-
October 31, 2008
Third-quarter 2008 Results
-
September 01, 2008
Sanofi-aventis acquisition of Symbion Consumer in Australia now completed
-
August 05, 2008
IMPORTANT NOTICE regarding the supply of Lovenox (Clexane) 100mg/1.0mL from August to October 2008
-
July 21, 2008
Sanofi-aventis enters into agreement with Primary Health Care to acquire “Symbion Consumer”, its nutraceuticals & OTC division, in Australia
-
July 04, 2008
Urgent medicine recall for product correction - extension of recall - Letter to pharmacists
-
July 04, 2008
Urgent medicine recall for product correction - extension of recall - Letter to doctors
-
June 17, 2008
Urgent medicine recall for product correction - extension of recall - Letter to doctors
-
June 17, 2008
Urgent medicine recall for product correction - extension of recall - Letter to pharmacists
-
May 27, 2008
Urgent advice re medicine recall for product correction - Letter to pharmacists
-
May 27, 2008
Urgent advice re medicine recall for product correction - Letter to doctors
-
April 30, 2008
Encouraging first-quarter 2008 results - Further positive Phase III results for eplivanserin
-
April 22, 2008
Malaria: strong partnerships aiming to benefit patients in Africa
-
March 07, 2008
Filing of the 2007 U.S. Form 20-F and French “Document de Référence” and Annual Financial Report
-
March 07, 2008
Sanofi-aventis Board of Directors
-
March 07, 2008
20-F 2007 sanofi-aventis
-
February 12, 2008
2007 full-year Global results
|
|
